NCT04344912 Impact of COVID19 Outbreak in Cardiac Acute Care
| NCT ID | NCT04344912 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Acute Coronary Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-03-20 |
| Primary Completion | 2024-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-03-20 with a primary completion date of 2024-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registry will evaluate the impact of the COVID19 outbreak on Cardiac patients admitted in the Intensive Care Unit of the Pitie-Salpetriere Hospital in Paris, France
Eligibility Criteria
Inclusion Criteria: * 18 years and older * Admitted in the Cardiac Intensive Care Unit from March 20th 2020 * Patient informed and having expressed his non-opposition to participate in the research Exclusion Criteria: * Minor patient * Patient who expressed opposition to participation in the study
Contact & Investigator
Johanne SILVAIN, MD PhD
STUDY DIRECTOR
Sorbonne University, ACTION Group, AP-HP Pitié-Salpêtrière Hospital Paris France
Frequently Asked Questions
Who can join the NCT04344912 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04344912 currently recruiting?
Yes, NCT04344912 is actively recruiting participants. Contact the research team at johanne.silvain@aphp.fr for enrollment information.
Where is the NCT04344912 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT04344912 clinical trial?
NCT04344912 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Johanne SILVAIN, MD PhD at Sorbonne University, ACTION Group, AP-HP Pitié-Salpêtrière Hospital Paris France. The trial plans to enroll 500 participants.